Loxo Oncology Inc secures Downside Deviation of 3.22, Mean Deviation of 2.37 and Risk Adjusted Performance of 0.2244. In connection with Fundamental Indicators, Macroaxis technical analysis interface lets you check existing technical drivers of Loxo Oncology Inc as well as the relationship between them. Strictly speaking you can use this information to find out if the firm will indeed mirror its model of past prices or the prices will eventually revert. We found nineteen technical drivers for Loxo Oncology which can be compared to its peers in the industry. Please verify Loxo Oncology Inc Standard Deviation as well as the relationship between Value At Risk and Kurtosis to decide if Loxo Oncology Inc is priced some-what accurately providing market reflects its recent price of 118.4 per share. Given that Loxo Oncology Inc has Jensen Alpha of 0.5701, we recommend you check Loxo Oncology last-minute market performance to make sure the company can sustain itself at future point.
|Time Horizon||30 Days Login to change|
Loxo Oncology Inc Technical Analysis
Loxo Oncology Inc Trend AnalysisUse this graph to draw trend lines for Loxo Oncology Inc. You can use it to identify possible trend reversals for Loxo Oncology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Loxo Oncology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
Loxo Oncology Best Fit Change LineThe following chart estimates an ordinary least squares regression model for Loxo Oncology Inc applied against its price change over selected period. The best fit line has a slop of 0.96 % which means Loxo Oncology Inc will continue generating value for investors. It has 34 observation points and a regression sum of squares at 759.46, which is the sum of squared deviations for the predicted Loxo Oncology price change compared to its average price change.
Loxo Oncology Inc is rated fifth overall in mean deviation category among related companies. It is currently under evaluation in standard deviation category among related companies creating about 1.29 of Standard Deviation per Mean Deviation. The ratio of Standard Deviation to Mean Deviation for Loxo Oncology Inc is roughly 1.29